ACUT Accustem Sciences Inc.

CIK 0001850767 3 ready 8-Ks latest November 26, 2025, 6:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 3

Latest filing November 26, 2025, 6:59 PM ET

Top materiality 0.70

Event mix regulatory ×1 · other ×1 · other_material ×1

Sentiment 1 pos · 0 neg · 2 neu

Recent 8-K filings for ACUT

Highest-materiality recent filing

AccuStem submits Medicare coverage application for MSC lung cancer test; enters Novitas review

November 26, 2025, 6:59 PM ET regulatory materiality 0.70 positive item 8.01

Submitted local coverage determination to Novitas Solutions for MSC test reimbursement.
Novitas confirmed application complete and valid; now in review queue for JL region (DC, DE, MD, NJ, PA).

November 26, 2025, 6:59 PM ET regulatory materiality 0.70 positive item 8.01

AccuStem submits Medicare coverage application for MSC lung cancer test; enters Novitas review

Submitted local coverage determination to Novitas Solutions for MSC test reimbursement.
January 2, 2025, 6:59 PM ET other materiality 0.10 neutral item 4.01 ◈ Auditor Changes

AccuStem Sciences amends 8-K to correct name of independent accounting firm

Amendment to Dec 30, 2024 8-K solely to revise the name of the independent registered public accounting firm.
December 30, 2024, 6:59 PM ET other material materiality 0.50 neutral item 4.01

AccuStem Sciences appoints Mercurius LLP as new auditor

Mercurius LLP appointed as AccuStem Sciences' independent registered public accounting firm effective June 17, 2024.

Max materiality 0.70 · Median 0.50 · Most common event regulatory

1 positive 0 negative 2 neutral